Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 8 | 2015 | 175 | 1.480 |
Why?
|
| Alzheimer Disease | 15 | 2024 | 250 | 1.290 |
Why?
|
| Stress, Psychological | 3 | 2013 | 24 | 0.870 |
Why?
|
| Cognition | 9 | 2024 | 220 | 0.840 |
Why?
|
| Aging | 4 | 2015 | 204 | 0.710 |
Why?
|
| Aged | 21 | 2024 | 956 | 0.610 |
Why?
|
| Neuropsychological Tests | 7 | 2018 | 238 | 0.570 |
Why?
|
| Female | 22 | 2024 | 1724 | 0.540 |
Why?
|
| Male | 22 | 2024 | 1860 | 0.530 |
Why?
|
| Stroke | 5 | 2016 | 49 | 0.520 |
Why?
|
| Humans | 24 | 2024 | 2957 | 0.510 |
Why?
|
| Cerebrovascular Disorders | 2 | 2015 | 7 | 0.490 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 567 | 0.410 |
Why?
|
| Apolipoproteins E | 5 | 2005 | 34 | 0.370 |
Why?
|
| Longitudinal Studies | 10 | 2018 | 260 | 0.360 |
Why?
|
| Cognitive Dysfunction | 3 | 2018 | 165 | 0.330 |
Why?
|
| Brain | 5 | 2024 | 202 | 0.290 |
Why?
|
| Chicago | 5 | 2018 | 160 | 0.280 |
Why?
|
| Dietary Supplements | 3 | 2006 | 16 | 0.270 |
Why?
|
| Risk Factors | 12 | 2018 | 275 | 0.260 |
Why?
|
| Apolipoprotein E4 | 7 | 2018 | 76 | 0.260 |
Why?
|
| Vitamin B 6 | 1 | 2006 | 3 | 0.250 |
Why?
|
| Vitamin B 12 | 1 | 2006 | 8 | 0.240 |
Why?
|
| Folic Acid | 1 | 2006 | 10 | 0.240 |
Why?
|
| Incidence | 8 | 2018 | 110 | 0.230 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 46 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 92 | 0.210 |
Why?
|
| Risk | 5 | 2015 | 44 | 0.200 |
Why?
|
| Diet | 3 | 2006 | 36 | 0.160 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 147 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2024 | 233 | 0.150 |
Why?
|
| Genetic Loci | 2 | 2016 | 13 | 0.140 |
Why?
|
| Cognitive Aging | 1 | 2018 | 27 | 0.130 |
Why?
|
| Surveys and Questionnaires | 4 | 2016 | 142 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 13 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 46 | 0.120 |
Why?
|
| White Matter | 1 | 2015 | 8 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 7 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2015 | 20 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 105 | 0.100 |
Why?
|
| Antioxidants | 2 | 2005 | 17 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2016 | 203 | 0.100 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cerebral Infarction | 1 | 2013 | 18 | 0.100 |
Why?
|
| Self Report | 1 | 2013 | 20 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2013 | 7 | 0.100 |
Why?
|
| Social Support | 1 | 2012 | 7 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2012 | 14 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 77 | 0.090 |
Why?
|
| Depression | 1 | 2012 | 59 | 0.090 |
Why?
|
| Genotype | 2 | 2016 | 85 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 51 | 0.080 |
Why?
|
| United States | 4 | 2018 | 243 | 0.080 |
Why?
|
| Age Factors | 4 | 2012 | 89 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2005 | 13 | 0.070 |
Why?
|
| Vitamin E | 2 | 2005 | 13 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2006 | 51 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 3 | 0.060 |
Why?
|
| Clergy | 1 | 2005 | 4 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2005 | 34 | 0.050 |
Why?
|
| Alleles | 3 | 2016 | 65 | 0.050 |
Why?
|
| Healthy Lifestyle | 1 | 2024 | 13 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 28 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 6 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2003 | 14 | 0.050 |
Why?
|
| Memory | 1 | 2002 | 48 | 0.050 |
Why?
|
| Middle Aged | 2 | 2015 | 792 | 0.050 |
Why?
|
| Dementia | 2 | 2017 | 73 | 0.040 |
Why?
|
| Nutrition Assessment | 3 | 2005 | 18 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 6 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 5 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 75 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2016 | 65 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 2 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 8 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 14 | 0.030 |
Why?
|
| Logistic Models | 2 | 2005 | 60 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 27 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 72 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 208 | 0.020 |
Why?
|
| Bias | 1 | 2006 | 6 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2006 | 19 | 0.020 |
Why?
|
| Community Health Services | 1 | 2006 | 8 | 0.020 |
Why?
|
| Comorbidity | 1 | 2006 | 49 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 83 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 74 | 0.010 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 3 | 0.010 |
Why?
|
| gamma-Tocopherol | 1 | 2005 | 3 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2003 | 3 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 4 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 4 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 6 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2003 | 32 | 0.010 |
Why?
|
| Urban Population | 1 | 2003 | 23 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 39 | 0.010 |
Why?
|
| Educational Status | 1 | 2003 | 41 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 99 | 0.010 |
Why?
|
| Memory Disorders | 1 | 2003 | 33 | 0.010 |
Why?
|
| beta Carotene | 1 | 2002 | 4 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 10 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 15 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2002 | 27 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 13 | 0.010 |
Why?
|